Primis Financial Corp: Raymond James cuts target price to $17 from $18
FRST•Raymond James cut its target price for Primis Financial Corp to $17 from $18.
Related News
Mirum to present Phase 3 Brelovitug data in chronic hepatitis D at AASLD meeting
MIRM•
Lyell Immunopharma to participate in Goldman Sachs, Stifel and Jefferies investor events
LYEL•
Zurn Elkay makes America’s greenest companies list for third consecutive year
ZWS•
Gold.com names Nick Bowkett vice president of trading and business development
GOLD•
FDA to review uniQure's Huntington's gene therapy, decision due May 1, 2027
QURE•